Page last updated: 2024-08-21

pyrazines and Orthomyxoviridae Infections

pyrazines has been researched along with Orthomyxoviridae Infections in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (7.14)29.6817
2010's10 (71.43)24.3611
2020's3 (21.43)2.80

Authors

AuthorsStudies
Kawaoka, Y; Kiso, M; Yamayoshi, S1
Abed, Y; Baz, M; Boivin, G; Checkmahomed, L; Padey, B; Pizzorno, A; Rosa-Calatrava, M; Terrier, O1
Akinbami, O; Barclay, WS; Frise, R; Galiano, M; Gallego Cortés, A; Goldhill, DH; Lackenby, A; Miah, S; Shelley, J; Yan, A; Zambon, M; Zhou, J1
Bank, C; Bolon, DN; Finberg, RW; Jensen, JD; Kowalik, TF; Liu, P; Matuszewski, S; Ormond, L; Renzette, N; Wang, JP; Zeldovich, K1
Hasegawa, H; Ito, M; Kawaoka, Y; Kiso, M; Lopes, TJS; Nakajima, N; Neumann, G; Yamashita, M; Yamayoshi, S1
Baz, M; Boivin, G; Carbonneau, J; Cavanagh, MH; Rhéaume, C1
Govorkova, EA; Marathe, BM; Pascua, PNQ; Vogel, P; Webby, RJ1
Bailey, T; Boon, ACM; Bricker, TL; Diamond, MS; Gounder, AP; Jagger, BW; Janowski, AB; Kwon, JH; Shafiuddin, M; Wang, D; Williams, GD; Zhao, G1
Bae, JY; Baek, LJ; Cheong, HJ; Heo, J; Hwang, MW; Jang, SI; Kim, D; Kim, H; Kim, JI; Lee, I; Lee, S; Park, MS; Park, S; Song, JW; Song, KJ1
Garcia-Alcalde, F; Govorkova, EA; Marathe, BM; Najera, I; Vogel, P; Webby, RJ; Webster, RG; Wong, SS1
Bailey, KW; Furuta, Y; Hurst, BL; Morrey, JD; Smee, DF; Tarbet, EB; Wong, MH1
Lee, SM; Yen, HL1
Armstrong, J; Baranovich, T; Govorkova, EA; Marjuki, H; Webby, RJ; Webster, RG; Wong, SS1
Egawa, H; Fukuda, Y; Furuta, Y; Kamiyama, T; Kozaki, K; Kuno, M; Minami, S; Nomura, N; Shiraki, K; Takahashi, K1

Reviews

1 review(s) available for pyrazines and Orthomyxoviridae Infections

ArticleYear
Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection.
    Antiviral research, 2012, Volume: 96, Issue:3

    Topics: Amides; Animals; Antibodies, Viral; Antiviral Agents; Cross Reactions; Host-Pathogen Interactions; Humans; Immunomodulation; Influenza A virus; Orthomyxoviridae Infections; Pyrazines; Receptors, Cell Surface; Viral Matrix Proteins; Virus Attachment; Virus Internalization; Virus Replication

2012

Other Studies

13 other study(ies) available for pyrazines and Orthomyxoviridae Infections

ArticleYear
Triple combination therapy of favipiravir plus two monoclonal antibodies eradicates influenza virus from nude mice.
    Communications biology, 2020, 05-07, Volume: 3, Issue:1

    Topics: Amides; Animals; Antibodies, Monoclonal; Antiviral Agents; Drug Therapy, Combination; Female; Hemagglutinins, Viral; Influenza A Virus, H1N1 Subtype; Mice; Mice, Nude; Orthomyxoviridae Infections; Pyrazines

2020
In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses.
    Viruses, 2020, 10-08, Volume: 12, Issue:10

    Topics: Acids, Carbocyclic; Amides; Animals; Antiviral Agents; Cell Line; Dibenzothiepins; Dogs; Drug Combinations; Drug Resistance, Viral; Drug Synergism; Guanidines; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Madin Darby Canine Kidney Cells; Morpholines; Neuraminidase; Nucleic Acid Synthesis Inhibitors; Orthomyxoviridae Infections; Oseltamivir; Pyrazines; Pyridones; Ribavirin; Triazines; Viral Proteins; Virus Replication; Zanamivir

2020
Favipiravir-resistant influenza A virus shows potential for transmission.
    PLoS pathogens, 2021, Volume: 17, Issue:6

    Topics: Amides; Animals; Antiviral Agents; Drug Resistance, Viral; Ferrets; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Orthomyxoviridae Infections; Pyrazines

2021
The Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolution.
    Genome biology and evolution, 2017, 07-01, Volume: 9, Issue:7

    Topics: Amides; Animals; Antiviral Agents; Biological Evolution; Cell Line; Dogs; Genetics, Population; Influenza A virus; Mutation Rate; Orthomyxoviridae Infections; Oseltamivir; Pyrazines

2017
Combination Therapy With Neuraminidase and Polymerase Inhibitors in Nude Mice Infected With Influenza Virus.
    The Journal of infectious diseases, 2018, 03-05, Volume: 217, Issue:6

    Topics: Amides; Animals; Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Female; Guanidines; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Lung; Mice; Mice, Inbred BALB C; Mice, Nude; Neuraminidase; Nucleic Acid Synthesis Inhibitors; Orthomyxoviridae Infections; Oseltamivir; Pyrans; Pyrazines; Sialic Acids; Zanamivir

2018
Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus.
    Viruses, 2018, 11-03, Volume: 10, Issue:11

    Topics: Amides; Animals; Antiviral Agents; Cytokines; Disease Models, Animal; Drug Resistance, Viral; Drug Therapy, Combination; Female; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Mice; Orthomyxoviridae Infections; Oseltamivir; Pyrazines

2018
Optimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model.
    The Journal of antimicrobial chemotherapy, 2019, 05-01, Volume: 74, Issue:5

    Topics: Administration, Oral; Amides; Animals; Antiviral Agents; Disease Models, Animal; Dogs; Epithelial Cells; Female; Immunocompromised Host; Influenza B virus; Madin Darby Canine Kidney Cells; Mice; Mice, Inbred BALB C; Mice, SCID; Orthomyxoviridae Infections; Pyrazines; Viral Load; Virus Replication

2019
Therapeutic efficacy of favipiravir against Bourbon virus in mice.
    PLoS pathogens, 2019, Volume: 15, Issue:6

    Topics: Amides; Animals; Antiviral Agents; Chlorocebus aethiops; Disease Models, Animal; Humans; Mice; Mice, Knockout; Orthomyxoviridae Infections; Pyrazines; Receptor, Interferon alpha-beta; Thogotovirus; Vero Cells; Viral Tropism

2019
Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.
    PloS one, 2014, Volume: 9, Issue:7

    Topics: Acids, Carbocyclic; Amides; Animals; Antiviral Agents; Body Weight; Cyclopentanes; Dogs; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Female; Guanidines; Influenza A Virus, H1N1 Subtype; Lung; Madin Darby Canine Kidney Cells; Mice; Mice, Inbred DBA; Orthomyxoviridae Infections; Oseltamivir; Pyrazines; Survival Rate

2014
Combinations of Oseltamivir and T-705 Extend the Treatment Window for Highly Pathogenic Influenza A(H5N1) Virus Infection in Mice.
    Scientific reports, 2016, 05-25, Volume: 6

    Topics: Amides; Animals; Dogs; Drug Therapy, Combination; Female; Influenza A Virus, H5N1 Subtype; Madin Darby Canine Kidney Cells; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir; Pyrazines

2016
Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Amides; Animals; Antiviral Agents; Cell Line; Drug Combinations; Drug Interactions; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Mice; Mice, Inbred BALB C; Neuraminidase; Orthomyxoviridae Infections; Oseltamivir; Pyrazines

2010
T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro.
    Journal of virology, 2013, Volume: 87, Issue:7

    Topics: Amides; Analysis of Variance; Animals; Antiviral Agents; Dogs; Drug Discovery; In Vitro Techniques; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Mutagenesis; Orthomyxoviridae Infections; Pyrazines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction

2013
In vitro and in vivo activities of T-705 and oseltamivir against influenza virus.
    Antiviral chemistry & chemotherapy, 2003, Volume: 14, Issue:5

    Topics: Acetamides; Amides; Animals; Antiviral Agents; Drug Evaluation, Preclinical; Influenza A virus; Mice; Orthomyxoviridae Infections; Oseltamivir; Pyrazines; Survival Rate; Time Factors

2003